ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 2888

$828K Total Retail Price of All Prescriptions

Rank: 326 out of 2888

685 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 685 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 17,812 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 963 914 1 1
METFORMIN HCL 757 656 2 8
OMEPRAZOLE 714 658 3 7
AMLODIPINE BESYLATE 712 678 4 5
FUROSEMIDE 591 513 5 6
LISINOPRIL 542 491 6 3
HYDROCODONE-ACETAMINOPHEN 485 443 S3 7 4
SIMVASTATIN 480 469 8 2
POTASSIUM CHLORIDE 442 413 9 14
MELOXICAM 405 356 10 31
METOPROLOL TARTRATE 405 363 10 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 392 345 12 28
PRAVASTATIN SODIUM 369 323 13 12
ALENDRONATE SODIUM 326 326 14 23
FLUTICASONE PROPIONATE 304 250 15 32
HYDROCHLOROTHIAZIDE 285 267 16 15
GLYBURIDE-METFORMIN HCL 278 264 R 17 64
LOVASTATIN 272 192 18 41
CLOPIDOGREL 240 218 19 30
GLYBURIDE 221 190 R 20 58
CITALOPRAM HBR 220 209 21 24
CRESTOR 219 192 22 20
WARFARIN SODIUM 211 180 23 22
PLAVIX 187 177 24 40
ATENOLOL 175 149 25 25
NEXIUM 172 155 26 19
ZOLPIDEM TARTRATE 172 168 26 17
METOPROLOL SUCCINATE 170 166 28 11
AZITHROMYCIN 168 140 29 38
TRAMADOL HCL 168 138 29 16
DONEPEZIL HCL 164 164 31 26
DOXYCYCLINE HYCLATE 157 140 32 123
ALLOPURINOL 149 129 33 37
ATORVASTATIN CALCIUM 140 133 34 9
BENAZEPRIL HCL 135 129 35 77
GABAPENTIN 133 130 36 13
TRAMADOL HCL-ACETAMINOPHEN 130 124 37 95
DIGOXIN 129 129 38 55
GLIPIZIDE 124 110 39 50
LANTUS 122 94 40 45
AMLODIPINE BESYLATE-BENAZEPRIL 120 108 41 67
CARVEDILOL 120 101 41 21
RANITIDINE HCL 117 115 43 56
ETODOLAC 113 83 44 170
TAMSULOSIN HCL 109 105 45 29
CLOTRIMAZOLE-BETAMETHASONE 109 93 45 136
CYCLOBENZAPRINE HCL 108 89 R 47 68
METFORMIN HCL ER 102 89 48 53
CIPROFLOXACIN HCL 102 89 48 47
SERTRALINE HCL 99 91 50 27
MOEXIPRIL-HYDROCHLOROTHIAZIDE 98 98 10 51 486
LOSARTAN-HYDROCHLOROTHIAZIDE 97 90 52 46
VERAPAMIL ER 91 90 53 104
ISOSORBIDE MONONITRATE ER 90 75 54 51
DIOVAN 90 55 54 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 76 56 88
HUMULIN N 86 50 56 267
DILTIAZEM ER 85 77 58 182
JANUVIA 84 79 59 48
SPIRIVA 82 80 60 79
RAMIPRIL 80 80 61 73
DIOVAN HCT 77 63 62 61
FLUOXETINE HCL 76 76 63 83
BENICAR HCT 76 72 63 181
CEFDINIR 71 59 65 194
PREDNISONE 69 58 66 42
LACTULOSE 69 41 66 111
METHYLPREDNISOLONE 69 63 66 101
GEMFIBROZIL 69 68 66 98
NAMENDA 68 68 70 34
PANTOPRAZOLE SODIUM 67 67 71 33
ENALAPRIL MALEATE 66 53 72 49
MECLIZINE HCL 65 64 73 122
ESTRADIOL 65 61 R 73 139
CELEBREX 62 54 75 89
MEGESTROL ACETATE 62 62 R 75 140
INSULIN SYRINGE 61 31 77 86
BENICAR 60 60 78 138
QUINAPRIL HCL 60 40 78 179
CYMBALTA 58 48 80 44
ESCITALOPRAM OXALATE 57 57 81 62
SUCRALFATE 57 52 81 187
DICYCLOMINE HCL 56 50 83 224
TRIAMTERENE-HCTZ 51 51 84 63
GLIPIZIDE ER 50 29 85 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.